Haptoglobin Reagent Market size is projected to grow at around 8.2% CAGR during the forecast period i.e., between 2024-2036. The growth of the market is projected to the rising prevalence of anemia. World Health Organization (WHO) published a report showing that in 2019, 29.9% of women aged between 15 to 49 and 36.5% of pregnant women were found to be affected with anemia.
Furthermore, the global haptoglobin reagent market is projected to grow on the back of various growth factors such as, renal and chronic diseases. Haptoglobin, an acute phase protein, is produced by the liver and binds up hemoglobin to prevent renal damage and iron loss. Haptoglobin is found at 45 milligrams per deciliter of blood and if it gets any lower than that, serious conditions can arouse within the body. Rising net national income per capita is further anticipated to propel the growth of the market over the forecast period. World Bank released a set of data showing 8,784 net national income per capita in 2020. National income per capita demonstrated by World Bank for each country in the similar year was Australia (39,193), Brazil (5,758), Canada (34,808), China (7,540), Germany (38,407), India (1,682), and others.
Growth Drivers
Rising Cases of Kidney Disease to Hike the Growth of the Market - As of 2022, about 80,000 new cases of kidney cancer are estimated to be diagnosed.
Rising Geriatric Population with Severe Renal Diseases - Based on the report provided by World Bank, in 2020, the global geriatric population was 747,238,580.
Growing per Capita Healthcare Expenditure - World Bank released a set of data demonstrating the healthcare expenditure per capita to be USD 1,121.97 in 2019.
Higher Prevalence of Stomach Diseases - National Library of Medicine published a report showing that there were around 17.7 million cases of acute appendicitis in 2019.
Spiking Incidences of Autoimmune Hemolytic Anemia - It observed that warm autoimmune hemolytic anemia (WAHA) affects about 1 to 2 per 100,000 individuals every year.
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024–2036 |
|
CAGR |
8.2% |
|
Regional Scope |
|
The global haptoglobin reagent market is segmented and analyzed for demand and supply by end-user into clinics, diagnostic laboratories, and hospitals, out of which, the hospitals segment is anticipated to hold the notable share in the global haptoglobin reagent market during the forecast period. The growth of the segment is attributed to the provision of better medical facilities. Hospitals have multiple departments available in a single place to run the requisite test.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By End-User |
|
Regionally, the global haptoglobin reagent market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North America industry is predicted to hold largest revenue share by 2036, propelled by rising cases of anemia and kidney diseases in the region. Data released by the National Hospital Ambulatory Medical Care Survey in 2018, 890,000 visits of people with anemia were noticed to the emergency departments in the United States. Furthermore, the rising mortality rate owing to anemia in the region is also anticipated to drive the growth of the market during the forecast period. Haptoglobin also prevents renal damage that is associated with kidney disease, meanwhile, a higher prevalence of kidney disease can be observed in the region. The National Kidney Foundation provided data, that in 2018, about 80 million adults were diagnosed with kidney diseases in the United States making it 1 out of 3 people. Hence, such factors are anticipated to foster the growth of the market over the forecast period.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?